# US 2022/0010279 A1 · Kits and methods for performing optical dynamic clamp on excitable cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0010279 A1
- Document ID: US20220010279A1
- Status: Published application
- Kind: A1
- Application number: 17/282,181
- Filed: 2019-10-01
- Published: 2022-01-13
- Earliest claimed: 2018-10-01
- Applicants: Cornell University; The George Washington University
- Inventors: Bonnie QUACH; Trine KROGH-MADSEN; David J. CHRISTINI; Emilia ENTCHEVA
- Web page: https://patentgrep.com/patent/US20220010279A1

## CPC

- C12N 5/0657: {Cardiomyocytes; Heart cells}
- C12N 5/0068: {General culture methods using substrates (for specific animal cell type C12N5/06)}
- C12N 5/0696: {Artificially induced pluripotent stem cells, e.g. iPS}
- G16B 99/00: Subject matter not provided for in other groups of this subclass
- C12N 2506/45: from artificially induced pluripotent stem cells
- C12N 2529/00: Culture process characterised by the use of electromagnetic stimulation
- C12N 2710/10343: viral genome or elements thereof as genetic vector
- C12N 2750/14143: viral genome or elements thereof as genetic vector
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

The present disclosure is directed to kits and methods for performing optical dynamic clamping on an excitable cell. In some embodiments, the excitable cell is selected from the group consisting of a neuron, a muscle cell and an excitable cell derived from an induced Pluripotent Stem Cell (IPSC). In a specific embodiment, the muscle cell is a cardiomyocyte.

## Claims

### Claim 1

A kit comprising:
an excitable cell expressing at least one light-sensitive protein from an exogenous nucleic acid, wherein the light sensitive protein is selected from the group consisting of a light-sensitive ion channel and a light-sensitive ion pump; and
a computer readable media comprising instructions for performing an optical dynamic clamp on the cell, wherein the instructions comprise calculating a target ion current based on a measured membrane potential (Vm) using a predetermined relationship between a time-dependent Vm and an ion current; and calculating a target light intensity based on the target ion current, wherein exposing the excitable cell to the target light intensity results in an ion current from the light-sensitive protein that is equal to the target ion current.

### Claim 2 (depends on 1)

The kit of claim 1, wherein the at least one light sensitive protein is selective for an ion selected from the group consisting of a potassium ion, a sodium ion, a chloride ion, a H+ ion and a calcium ion.

### Claim 3 (depends on 1)

The kit of claim 1, wherein the excitable cell is selected from the group consisting of a neuron, a muscle cell and an excitable cell derived from an induced Pluripotent Stem Cell (iPSC).

### Claim 4 (depends on 3)

The kit of claim 3, wherein the muscle cell is a cardiomyocyte.

### Claim 5 (depends on 4)

The kit of claim 4, wherein the cardiomyocyte is an induced Pluripotent Stem Cell (iPSC)-derived cardiomyocyte.

### Claim 6 (depends on 1)

The kit of claim 1, wherein the at least one light-sensitive protein is a channelrhodopsin, an anion-conducting channelrhodopsin, or a chimeric channelrhodopsin.

### Claim 7 (depends on 6)

The kit of claim 6, wherein the channelrhodopsin is selected from the group consisting of Channelrhodopsin 1 (ChR1), Channelrhodopsin (ChR2), Volvox channelrhodopsin (VChR1), and Step function or bi-stable opsins (SFOs).

### Claim 8 (depends on 1)

The kit of claim 1, wherein the light-sensitive protein is selected from a halorhodopsin (NpHR), an enhanced halorhodopsin eNpHR2.0, an enhanced halorhodopsin eNpHR3.0, an archaerhodopsin (Arch), the fungal opsin Mac and an enhanced bacteriorhodopsin (eBR).

### Claim 9 (depends on 1)

The kit of claim 1, wherein the excitable cell expresses two different light-sensitive proteins, wherein each light sensitive protein is activated by a different wavelength of light.

### Claim 10 (depends on 9)

The kit of claim 9, wherein one of the light sensitive proteins depolarizes the excitable cell when activated, and wherein the other light sensitive protein hyperpolarizes the excitable cell when activated.

### Claim 11

A method for modulating the electrophysiology of a cell comprising:
(i) providing an excitable cell, an electrode, and a light source with a controllable light intensity or a controllable light wavelength, wherein the excitable cell expresses at least one light-sensitive protein from an exogenous nucleic acid, and wherein the light-sensitive protein is selected from a light-sensitive ion channel or a light-sensitive ion pump;
(ii) forming a high resistance electrical seal between the electrode and a membrane of the cell;
(iii) measuring the membrane potential (Vm) of the cell with the electrode;
(iv) calculating a target ion current based on the measured Vm using a predetermined relationship between a time-dependent Vm and an ion current; and
(v) adjusting the light intensity or the light wavelength of the light source thereby controlling an ion current from the light-sensitive protein until the measured ion current is equal to the target ion current.

### Claim 12 (depends on 11)

The method of claim 11, further comprising repeating steps (iii) through (v).

### Claim 13 (depends on 11)

The method of claim 11, wherein the calculating and adjusting steps are carried out by a computer.

### Claim 14 (depends on 11)

The method of claim 11, wherein the predetermined relationship is determined from a control excitable cell.

### Claim 15 (depends on 11)

The method of claim 11, wherein step (iv) further comprises calculating a target light intensity based on the target ion current.

### Claim 16 (depends on 11)

The method of claim 11, wherein the at least one light-sensitive protein is selective for an ion selected from the group consisting of a potassium ion, a sodium ion, a chloride ion, a H+ ion and a calcium ion.

### Claim 17 (depends on 11)

The method of claim 11, wherein the excitable cell is selected from the group consisting of a neuron, a muscle cell and an excitable cell derived from an induced Pluripotent Stem Cell (iPSC).

### Claim 18 (depends on 17)

The method of claim 17, wherein the muscle cell is a cardiomyocyte.

### Claim 19 (depends on 18)

The method of claim 18, wherein the cardiomyocyte is an induced Pluripotent Stem Cell (iPSC)-derived cardiomyocyte.

### Claim 20 (depends on 11)

The method of claim 11, wherein the at least one light-sensitive protein is a channelrhodopsin, an anion-conducting channelrhodopsin, or a chimeric channelrhodopsin.

### Claim 21 (depends on 20)

The method of claim 20, wherein the channelrhodopsin is selected from the group consisting of Channelrhodopsin 1 (ChR1), Channelrhodopsin (ChR2), Volvox channelrhodopsin 1 (VChR1), and Step function or bi-stable opsins (SFOs).

### Claim 22 (depends on 11)

The method of claim 11, wherein the at least one light-sensitive protein is selected from a halorhodopsin (NpHR), an enhanced halorhodopsin eNpHR2.0, an enhanced halorhodopsin eNpHR3.0, an archaerhodopsin (Arch), the fungal opsin Mac and an enhanced bacteriorhodopsin (eBR).

### Claim 23 (depends on 11)

The method of claim 11, wherein the excitable cell expresses at least two different light-sensitive proteins, wherein each light sensitive protein is activated by a different wavelength of light.

### Claim 24

A method for modulating the electrophysiology of a cell comprising:
(i) providing an excitable cell, a light source with a controllable light intensity or light wavelength, and an optical detector, wherein the excitable cell expresses at least one light-sensitive protein from an exogenous nucleic acid, and wherein the light-sensitive protein is selected from a light-sensitive ion channel or a light-sensitive ion pump, and wherein the excitable cell further expresses an optogenetic sensor expressed from an exogenous nucleic acid, and wherein the optical detector produces a signal indicating a membrane potential (Vm);
(ii) measuring the Vm of the cell by measuring a signal from optogenic sensor with the optical detector;
(iii) calculating a target ion current based on the measured Vm using a predetermined relationship between a time-dependent Vm and an ion current;
(iv) adjusting the light intensity or the light wavelength of the light source thereby controlling an ion current from the light-sensitive protein until the measured ion current is equal to the target ion current.

### Claim 25 (depends on 24)

The method of claim 24, further comprising repeating steps (ii) through (iv).

### Claim 26 (depends on 24)

The method of claim 24, wherein the calculating and adjusting steps are carried out by a computer.

### Claim 27 (depends on 24)

The method of claim 24, wherein the predetermined relationship is determined from a control excitable cell.

### Claim 28 (depends on 24)

The method of claim 24, wherein step (iii) further comprises calculating a target light intensity based on the target ion current.

### Claim 29 (depends on 24)

The method of claim 24, wherein the light-sensitive protein is selective for an ion selected from the group consisting of a potassium ion, a sodium ion, a chloride ion, a H+ ion and a calcium ion.

### Claim 30 (depends on 24)

The method of claim 24, wherein the excitable cell is selected from the group consisting of a neuron, a muscle cell and an excitable cell derived from an induced Pluripotent Stem Cell (iPSC).

### Claim 31 (depends on 30)

The method of claim 30, wherein the muscle cell is a cardiomyocyte.

### Claim 32 (depends on 31)

The method of claim 31, wherein the cardiomyocyte is an induced Pluripotent Stem Cell (iPSC)-derived cardiomyocyte.

### Claim 33 (depends on 24)

The method of claim 24, wherein the light-sensitive protein is a channelrhodopsin, an anion-conducting channelrhodopsin, or a chimeric channelrhodopsin.

### Claim 34 (depends on 33)

The method of claim 33, wherein the channelrhodopsin is selected from the group consisting of Channelrhodopsin 1 (ChR1), Channelrhodopsin (ChR2), Volvox channelrhodopsin 1 (VChR1), and Step function or bi-stable opsins (SFOs).

### Claim 35 (depends on 24)

The method of claim 24, wherein the light-sensitive protein is selected from a halorhodopsin (NpHR), an enhanced halorhodopsin eNpHR2.0, an enhanced halorhodopsin eNpHR3.0, an archaerhodopsin (Arch), the fungal opsin Mac and an enhanced bacteriorhodopsin (eBR).

### Claim 36 (depends on 24)

The method of claim 24, wherein the optogenetic sensor is selected from the group consisting of arc lightning, D3cpVenus, G-CaMP and ASAP1.

### Claim 37 (depends on 11)

The method of claim 11, wherein the excitable cell expresses two different light-sensitive proteins, wherein each light sensitive protein is activated by a different wavelength of light.
